Evidence mapPaperPMID 38533504Full record

ArticleFrontiers in immunology2024

Interaction between peripheral blood mononuclear cells and

Leyllane Rafael Moreira, Ana Carla Silva, Cíntia Nascimento da Costa-Oliveira, Claudeir Dias da Silva-Júnior, Kamila Kássia Dos Santos Oliveira, Diego José Lira Torres, Michelle D Barros, Michelle Christiane D S Rabello, Virginia Maria Barros de Lorena

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Leyllane Rafael MoreiraDepartment of Tropical Medicine, Federal University of Pernambuco, Recife, Brazil.
Ana Carla SilvaDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Cíntia Nascimento da Costa-OliveiraDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Claudeir Dias da Silva-JúniorDepartment of Tropical Medicine, Federal University of Pernambuco, Recife, Brazil.
Kamila Kássia Dos Santos OliveiraDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Diego José Lira TorresDepartment of Tropical Medicine, Federal University of Pernambuco, Recife, Brazil.
Michelle D BarrosDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Michelle Christiane D S RabelloDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Virginia Maria Barros de LorenaDepartment of Immunology, Aggeu Magalhães Institute, Recife, Brazil.
Universidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Introduction: Adipose tissue (AT) has been highlighted as a promising reservoir of infection for viruses, bacteria and parasites. Among them is Methods: We performed indirect cultivation between T. cruzi-infected adipocytes, PBMC and the addition of BZ. After 72h of treatment, the supernatant was collected for cytokine, chemokine and adipokine assay. Infected adipocytes were removed to quantify T. cruzi DNA, and PBMC were removed for immunophenotyping. Results: Our findings showed elevated secretion of interleukin (IL)-6, IL-2 and monocyte chemoattractant protein-1 (MCP-1/CCL2) in the AT+PBMC condition compared to the other controls. In contrast, there was a decrease in tumor necrosis factor (TNF) and IL-8/CXCL-8 in the groups with AT. We also found high adipsin secretion in PBMC+AT+T compared to the treated condition (PBMC+AT+T+BZ). Likewise, the expression of CD80+ and HLA-DR+ in CD14+ cells decreased in the presence of T. cruzi. Discussion: Thus, our findings indicate that AT promotes up-regulation of inflammatory products such as IL-6, IL-2, and MCP-1/CCL2. However, adipogenic inducers may have triggered the downregulation of TNF and IL-8/CXCL8 through the peroxisome proliferator agonist gamma (PPAR-g) or receptor expression. On the other hand, the administration of BZ only managed to reduce inflammation in the microenvironment by decreasing adipsin in the infected culture conditions. Therefore, given the findings, we can see that AT is an ally of the parasite in evading the host's immune response and the pharmacological action of BZ.

Indexed as

Chagas DiseaseNitroimidazolesTrypanosoma cruziAdipocytesAdipose TissueComplement Factor DHumansImmunityInterleukin-2Interleukin-8Leukocytes, MononuclearTreatment FailureTumor Necrosis Factor-alphabenzonidazoleComplement Factor DInterleukin-2Interleukin-8NitroimidazolesTumor Necrosis Factor-alphaadipokineadipose tissuebenznidazolechemokinecytokineimmunomodulationTrypanosoma cruzi

Identifiers

PMID38533504
PMCPMC10963431
OpenAlexW4392712557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.